EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mapping Risk for Psychiatric Disorders to Brain Regions Using Spatial Transcriptomics

Aodán Laighneach

Biological Psychiatry Global Open Science · 2026-07 · 6 (4) · 100752

DOI: 10.1016/j.bpsgos.2026.100752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological Psychiatry Global Open Science, 2026-07. Verfasst von Aodán Laighneach. Beteiligte Einrichtung: Centre for Neuroimaging, Cognition and Genomics and Institute for Health Discovery and Innovation, University of Galway, Galway, Ireland. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spatial arrangement within a tissue encodes important information pertaining to the communication between cells, as well as the presence of nutrients and exposure to external stimuli (1). For brain tissue, this could represent, for example, neuronal connectivity and the relationship of neurons with nearby glial support cells. In some cases, such as when un-dertaking magnetic resonance imaging (MRI)-based investigations, it is possible to gain direct, high-precision spatial insights into brain structure or function, but these approaches do not infer molecular function. Techniques that do provide in-depth molecular data, such as traditional bulk RNA sequencing (RNA-seq) and, more recently, single-cell/nucleus RNA-seq, generally lack a precise spatial element. Spatial transcriptomics (ST), particularly sequencing-based ST, helps bridge this gap by combining high-throughput gene expression measurement and meaningful high-resolution positional information (2). These methods involve assaying the gene expression profiles of an array of many small, evenly spaced spots from a tissue capture area and using a combination of barcoded probes and high-resolution imaging taken before expression profiling to assign location. The approach used in a recent study by Baran et al. (3), published in Biological Psychiatry: Global Open Science, leverages these ST data (4) and a contemporary statistical approach (5) to provide valuable insights into how common genetic liability for schizophrenia (SCZ), bipolar disorder (BD), and major depression (MDD) may be partitioned spatially within subfields of the human hippocampus. As described in Song et al. (5), this is accomplished by 1) calculating gene specificity for each ST spot; 2) assigning gene specificity to variants based on their location and epigenetic maps; 3) performing stratified linkage disequilibrium score regression (s-LDSC) based on genome-wide association study (GWAS) summary statistics; and 4) aggregating individual spot p values to reflect a per-region enrichment statistic. Baran et al. (3) identified enriched regions and

Autor:innen und Institutionen

  • Centre for Neuroimaging, Cognition and Genomics and Institute for Health Discovery and Innovation, University of Galway, Galway, Ireland.

Zitieren

APA

Laighneach, A. (2026). Mapping Risk for Psychiatric Disorders to Brain Regions Using Spatial Transcriptomics. Biological Psychiatry Global Open Science, 6(4), 100752. https://doi.org/10.1016/j.bpsgos.2026.100752

Vancouver

Laighneach A. Mapping Risk for Psychiatric Disorders to Brain Regions Using Spatial Transcriptomics. Biological Psychiatry Global Open Science. 2026;6(4):100752. doi:10.1016/j.bpsgos.2026.100752

BibTeX
@article{Laighneach2026,
  author = {Laighneach, Aodán},
  title = {Mapping Risk for Psychiatric Disorders to Brain Regions Using Spatial Transcriptomics},
  journal = {Biological Psychiatry Global Open Science},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {100752},
  doi = {10.1016/j.bpsgos.2026.100752}
}
Kostenlos starten →